SEC Form 4 · accession 0001209191-17-054279
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Stevens
Director
Period of report
Sep 23, 2017
Accepted (ET)
Sep 28, 2017 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.60 | Sep 23, 2017 | A | 30,000 | A | — | Sep 23, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the date of grant.